SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 1,334.19 |
| Enterprise Value ($M) | 1,408.78 |
| Book Value ($M) | 24.58 |
| Book Value / Share | 0.09 |
| Price / Book | 54.28 |
| NCAV ($M) | -81.82 |
| NCAV / Share | -0.31 |
| Price / NCAV | -16.31 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.21 |
| Return on Assets (ROA) | -0.20 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.02 |
| Current Ratio | 2.23 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 203.78 |
| Assets | 310.19 |
| Liabilities | 285.60 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 160.18 |
| Operating Income | -46.21 |
| Net Income | -69.41 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -40.66 |
| Cash from Investing | -0.03 |
| Cash from Financing | 49.66 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Vanguard Group Inc | 5.37 | 66.75 | |
| 13G/A | BlackRock, Inc. | 6.10 | -0.36 | |
| 13G/A | Satter Muneer A | 2.60 | -64.53 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 697,023 | 3,439,080 | 20.27 | |
| 715,361 | 3,369,269 | 21.23 | |
| 584,091 | 2,846,010 | 20.52 | |
| 2,137,924 | 6,695,683 | 31.93 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| AGEN – Agenus Inc. | AIMD – Ainos, Inc. |
| AKAN – Akanda Corp. | ALDX – Aldeyra Therapeutics, Inc. |
| ALGS – Aligos Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io